Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 33, 2009 - Issue 5
153
Views
18
CrossRef citations to date
0
Altmetric
PROCEEDINGS 17TH ICOC Shenzhen, PR China, November 2007

The Role of Labile Iron in Kidney Disease and Treatment with Chelation

&
Pages 378-385 | Published online: 12 Oct 2009

REFERENCES

  • Halliwell B, Gutteridge JMC. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 1990; 186:1–85.
  • Kakhlon O, Cabantchik ZI. The labile iron pool: characterization, measurement, and participation in celullar processes. Free Radic Biol Med. 2002; 33(8):1037–1046.
  • Baliga R, Ueda N, Walker PD, Shah SV. Oxidant mechanisms in toxic acute renal failure. Drug Metab Rev. 1999; 31(4):971–997.
  • Ueda N, Mayeux PR, Baliga R, Shah SV. Oxidant mechanisms in acute renal failure. In: Molitoris B, Finn W, ed. Acute Renal Failure: A Companion to Brenner & Rector’s The Kidney. Philadelphia: W.B. Saunders Company; 2001:60–77.
  • Mehta RL, Kellum JA, Shah SV, Acute kidney injury network (AKIN): report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007; 11(2):R31.
  • Chertow GM, Burdick E, Honour M, Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005; 16(11):3365–3370.
  • Paller MS. Hemoglobin- and myoglobin-induced acute renal failure in rats: role of iron in nephrotoxicity. Am J Physiol. 1988; 255(24):F539–F544.
  • Rajapurkar M, Gang S, Hegde U, Study of urinary catalytic (bleomycin-detectable) iron following radiocontrast exposure in healthy kidney donors. J Am Soc Nephrol. 2007; 18(Abstracts issue):575A.
  • Hanss BG, Valencia SH, Shah SV, Vari RC. The iron chelator deferoxamine prevents contrast media induced acute renal failure in the rabbit. J Am Soc Nephrol. 1990; 1(4):612.
  • Shah SV, Baliga R, Fonseca VA, Rajapurkar M. Oxidants in chronic kidney disease. J Am Soc Nephrol. 2007; 18(1):16–28.
  • Rajapurkar MM, Alam MG, Bhattacharya A. Novel treatment for diabetic nephropathy. J Am Soc Nephrol. 2007; 18(Abstracts issue):329A.
  • Nankivell BJ, Boadle RA, Harris DCH. Iron accumulation in human chronic renal disease. Am J Kidney Dis. 1992; 20(6):580–504.
  • Lin J-L, Lin-Tan D-T, Hsu K-H, Yu C-C. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. N Engl J Med. 2003; 348(4):277–286.
  • Owda AK, Alam MG, Shah SV. Environmental lead exposure and chronic renal disease (letter). N Engl J Med. 2003; 348(18):1810.
  • Rajapurkar MM, Baliga R, Shah SV. Treatment of patients with glomerulonephritis with an oral iron chelator. J Am Soc Nephrol. 2007; 18(Abstracts issue):57–58A.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.